Sudarshan Pharma Industries share price
You have to be logged in to add this to Watchlist.- ₹26.74(-0.59%)February 11, 2026 13:31:32 PM IST
- NSE
- BSE
- Vol : 104.00 K (NSE + BSE)Last 20 day avg : 372.40 K
Sudarshan Pharma Industries is trading -0.59% lower at Rs 26.74 as compared to its last closing price. Sudarshan Pharma Industries has been trading in the price range of 26.90 & 26.00. Sudarshan Pharma Industries has given -2.36% in this year & 34.50% in the last 5 days. Listed peers of Sudarshan Pharma Industries include Divi's Laboratories (3.06%), Torrent Pharmaceuticals (-0.50%), Cipla (0.58%).The Mutual Fund holding in Sudarshan Pharma Industries was at -% in . The MF holding has - from the last quarter. The FII holding in Sudarshan Pharma Industries was at 19.78% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 11, 2026, 09:47 AM UTC
- Debt To EquityHigher than industry1.30The debt-to-equity ratio, indicating a company's financial leverage.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Dividend Yield-Annual dividends as a percentage of the stock price.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Moderately Bullish | 6,361.50 | 3.06 | 1,69,363.48 | 78.61 | 11.52 | 0.46 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,058.95 | -0.50 | 1,37,556.63 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Moderately Bearish | 1,349.90 | 0.58 | 1,09,041.11 | 22.95 | 3.87 | 0.87 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,269.30 | 1.08 | 1,05,812.49 | 18.63 | 3.14 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Bullish | 1,711.05 | 0.20 | 4,10,528.54 | 36.24 | 5.77 | 0.92 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-28 | Quarterly Results |
| 2025-10-18 | Half Yearly Results |
| 2025-08-14 | Quarterly Results |
| 2025-04-24 | Audited Results |
| 2025-01-10 | To consider issue of Warrants |
- IndustryBiotechnology & Drugs
- ISININE00TV01023
- BSE Code543828
- NSE Code
Sudarshan Pharma Industries is trading at 26.74 as on Wed Feb 11 2026 08:01:32. This is -0.59% lower as compared to its previous closing price of 26.90.
The market capitalization of Sudarshan Pharma Industries is 651.51 Cr as on Wed Feb 11 2026 08:01:32.
The 52 wk high for Sudarshan Pharma Industries is 36.45 whereas the 52 wk low is 18.50
Sudarshan Pharma Industries can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 25.21
- Dividend Yield: %
- D/E ratio: -
Sudarshan Pharma Industries reported a net profit of 15.95 Cr in 2025.